EpiVacCorona, the second Russian vaccine, claims 100% effectiveness
100% effectiveness and a booster every 3 years: the second Russian vaccine, EpiVacCorona, could mark a step forward ...
Read more100% effectiveness and a booster every 3 years: the second Russian vaccine, EpiVacCorona, could mark a step forward ...
Read moreA new medical approach to cancer, a vaccine called PD-1 Vaxx has achieved extraordinary results and approval for human trials
Read moreAn AstraZeneca vaccine at Covid-19 was also announced today. Here is a focus on positive results, on weaknesses ...
Read moreAn insight from a Mount Sinai team adds two ingredients to the melanoma vaccine that double its potency, ...
Read moreThe announcement of the Moderna vaccine (94,5% efficacy and storable at not excessive temperatures) makes the stock market and hopes fly. Caution also ...
Read moreWe have one vaccine that is 90% effective, or rather two. But how do you keep a cold chain on the planet ...
Read moreThe announcement of the efficacy of the Pfizer vaccine for Covid-19 raises stock market indices and hopes, but caution is needed
Read moreAll over the world it is a crazy race against time to find a coronavirus vaccine. The former can ...
Read moreInjected into the bloodstream, the nanoparticle containing gluten is exchanged for debris and removed without causing the symptoms of ...
Read moreThe studies to produce an HIV vaccine are continuing, and soon they could lead us to really, really decisive breakthroughs.
Read moreTo submit articles, disclose the results of a research or scientific discoveries write to the editorial staff
Futuroprossimo.it provides news on the future of technology, science and innovation: if there is something that is about to arrive, here it has already arrived. FuturoProssimo is part of the network ForwardTo, studies and skills for future scenarios.
© 2022 Near future -
This work is distributed under license Creative Commons Attribution 4.0 International.